Nernst equation

2,202views

Nernst equation

Watch later

Watch later

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
DNA cloning
ELISA (Enzyme-linked immunosorbent assay)
Fluorescence in situ hybridization
Gel electrophoresis and genetic testing
Karyotyping
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Acid-base map and compensatory mechanisms
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
The role of the kidney in acid-base balance
Metabolic acidosis
Plasma anion gap
Respiratory acidosis
Metabolic alkalosis
Respiratory alkalosis
Anaphylaxis
Food allergy
Type I hypersensitivity
Autoimmune hemolytic anemia
Goodpasture syndrome
Graves disease
Hemolytic disease of the newborn
Myasthenia gravis
Pemphigus vulgaris
Rheumatic heart disease
Type II hypersensitivity
Poststreptococcal glomerulonephritis
Serum sickness
Systemic lupus erythematosus
Type III hypersensitivity
Graft-versus-host disease
Type IV hypersensitivity
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
X-linked agammaglobulinemia
Adenosine deaminase deficiency
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Complement deficiency
Cytomegalovirus infection after transplant (NORD)
Chronic granulomatous disease
Leukocyte adhesion deficiency
DiGeorge syndrome
Glucocorticoids
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Vaccinations
Cytokines
Complement system
Innate immune system
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Oncogenes and tumor suppressor genes
Endocarditis
Myocarditis
Cardiac tumors
Myocardial infarction
Familial hypercholesterolemia
Hypertriglyceridemia
Cushing syndrome
Hypertension
Pheochromocytoma
Polycystic kidney disease
Renal artery stenosis
Lymphedema
Peripheral artery disease
Nutcracker syndrome
Superior mesenteric artery syndrome
Angiosarcomas
Human herpesvirus 8 (Kaposi sarcoma)
Vascular tumors
Behcet's disease
Kawasaki disease
Deep vein thrombosis
Thrombophlebitis
Adrenal cortical carcinoma
Hyperaldosteronism
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Congenital adrenal hyperplasia
Multiple endocrine neoplasia
Carcinoid syndrome
Neuroblastoma
Zollinger-Ellison syndrome
Hyperprolactinemia
Pituitary adenoma
Prolactinoma
Growth hormone deficiency
Hypopituitarism
Hypoprolactinemia
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyperthyroidism
Thyroid storm
Toxic multinodular goiter
Hashimoto thyroiditis
Hypothyroidism
Postpartum thyroiditis
Thyroid cancer
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Pathology review
Hyperthyroidism: Pathology review
Hypopituitarism: Pathology review
Hypothyroidism: Pathology review
Multiple endocrine neoplasia: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Pituitary tumors: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Hyperparathyroidism
Hypoparathyroidism
Biliary colic
Alcohol-associated liver disease
Alpha 1-antitrypsin deficiency
Autoimmune hepatitis
Benign liver tumors
Cirrhosis
Hemochromatosis
Viral hepatitis
Hepatocellular carcinoma
Jaundice
Neonatal hepatitis
Non-alcoholic fatty liver disease
Portal hypertension
Primary biliary cholangitis
Primary sclerosing cholangitis
Reye syndrome
Wilson disease
Acute pancreatitis
Chronic pancreatitis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sickle cell disease (NORD)
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Alpha-thalassemia
Anemia of chronic disease
Beta-thalassemia
Iron deficiency anemia
Sideroblastic anemia
Aplastic anemia
Mastocytosis (NORD)
Essential thrombocythemia (NORD)
Myelodysplastic syndromes
Myelofibrosis (NORD)
Polycythemia vera (NORD)
Acute leukemia
Chronic leukemia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Von Willebrand disease
Waldenstrom macroglobulinemia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Stevens-Johnson syndrome
Candida
Human herpesvirus 6 (Roseola)
Measles virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Coxsackievirus
Herpes simplex virus
Human papillomavirus
Ankylosing spondylitis
Gout
Rheumatoid arthritis
Septic arthritis
Osteoarthritis
Limited systemic sclerosis (CREST syndrome)
Raynaud phenomenon
Scleroderma
Sjogren syndrome
Pleural effusion
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Role of Vitamin K in coagulation
Amino acids and protein folding
Cell cycle
DNA damage and repair
DNA mutations
DNA replication
DNA structure
Epigenetics
Gene regulation
Mitosis and meiosis
Nuclear structure
Nucleotide metabolism
Transcription of DNA
Translation of mRNA
Cell membrane
Cell signaling pathways
Cell-cell junctions
Cellular structure and function
Endocytosis and exocytosis
Nernst equation
Osmosis
Acute intermittent porphyria
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anti-tumor antibiotics
DNA alkylating medications
Monoclonal antibodies
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Blood components
Erythropoietin
Bacillus anthracis (Anthrax)
Bacillus cereus (Food poisoning)
Corynebacterium diphtheriae (Diphtheria)
Listeria monocytogenes
Clostridium botulinum (Botulism)
Clostridium difficile (Pseudomembranous colitis)
Clostridium perfringens
Clostridium tetani (Tetanus)
Actinomyces israelii
Nocardia
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Streptococcus viridans
Enterococcus
Bacteroides fragilis
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Enterobacter
Escherichia coli
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Proteus mirabilis
Pseudomonas aeruginosa
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Serratia marcescens
Shigella
Yersinia enterocolitica
Yersinia pestis (Plague)
Campylobacter jejuni
Helicobacter pylori
Vibrio cholerae (Cholera)
Moraxella catarrhalis
Neisseria gonorrhoeae
Neisseria meningitidis
Bordetella pertussis (Whooping cough)
Brucella
Francisella tularensis (Tularemia)
Haemophilus ducreyi (Chancroid)
Haemophilus influenzae
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium avium complex (NORD)
Mycobacterium leprae
Chlamydia pneumoniae
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Mycoplasma pneumoniae
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Borrelia burgdorferi (Lyme disease)
Borrelia species (Relapsing fever)
Leptospira
Treponema pallidum (Syphilis)
Adenovirus
Hepatitis B and Hepatitis D virus
Epstein-Barr virus (Infectious mononucleosis)
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Prions (Spongiform encephalopathy)
Norovirus
Hepatitis C virus
West Nile virus
Yellow fever virus
Zika virus
Influenza virus
Human parainfluenza viruses
Mumps virus
Respiratory syncytial virus
Hepatitis A and Hepatitis E virus
Poliovirus
Rhinovirus
Rotavirus
HIV (AIDS)
Rabies virus
PDE5 inhibitors
Protease inhibitors
Cell wall synthesis inhibitors: Cephalosporins
Serotonin and norepinephrine reuptake inhibitors
Cell wall synthesis inhibitors: Penicillins
Monoamine oxidase inhibitors
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Anemia of chronic disease: Year of the Zebra
Myeloproliferative disorders: Pathology review
Leukemias: Pathology review
Coagulation disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Platelet disorders: Pathology review
Plasma cell disorders: Pathology review
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Methemoglobinemia
Pulmonary edema
Pulmonary embolism
Pulmonary shunts
Ventilation
Prerenal azotemia
Postrenal azotemia
Renal azotemia
Hyperkalemia
Hypermagnesemia
Hypercalcemia
Hypernatremia
Hypokalemia
Hyponatremia
Amyloidosis
Vitamin D
Antidiuretic hormone
Sodium homeostasis
Renin-angiotensin-aldosterone system
Parkinson disease
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Thyroid and parathyroid gland histology
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Hypoglycemics: Insulin secretagogues
Insulins
Miscellaneous hypoglycemics
Cortisol
Synthesis of adrenocortical hormones
Parathyroid hormone
Calcitonin
Phosphate, calcium and magnesium homeostasis
Adrenocorticotropic hormone
Growth hormone and somatostatin
Oxytocin and prolactin
Thyroid hormones
Celiac disease
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Bacterial structure and functions
Herpesvirus medications
Hepatitis medications
Trypanosoma cruzi (Chagas disease)
Plasmodium species (Malaria)

Flashcards

Nernst equation

0 of 13 complete

Transcript

Watch video only

The Nernst equation helps explain how a Galvanic cell works - so let’s start by drawing out a galvanic cell.

A galvanic cell has two electrodes - so for our example, let’s say there’s one solid zinc electrode and that it’s in a 1.0 molar solution of zinc-two-plus ions, and that there’s a solid copper electrode and it’s in a 1.0 molar solution of copper-two-plus ions.

Now, copper ions turn their solution a blue color, whereas zinc ions don’t color their solution - so it’s colorless.

Since the concentration of both copper and zinc ion solutions is 1.0 molar and if we assume that the temperature is 25 degrees celsius, then we’re under standard conditions.

Now, in our galvanic cell, the two electrodes are connected by a wire with an open switch and there’s also a salt bridge between the two compartments.

The salt bridge allows electrical charge to travel between the two solutions.

To get the galvanic cell started, we need to close the switch, so that electrons or electrical current can flow through the wire.

Now, if we want to calculate the cell potential, or cell voltage, for this zinc-copper cell, we need to use the Nernst equation.

So here’s the Nernst equation, E refers to the instantaneous voltage of the galvanic cell, or the voltage at a specific moment in time.

Enaught or Ezero is a constant called the “standard voltage,” and it’s simply based on the two metals that we’re using in our galvanic cell.

We can look up this number for zinc and copper, and we find that it has a value of +1.10 volts.

N refers to the number of moles of electrons that are transferred during the redox reaction.

Q is the reaction quotient, which is the ratio of the concentration of reactants to the concentration of products in our galvanic cell.

When we calculate this, we only include the concentration of the ions, and we leave out the pure solids like the zinc and copper electrodes. This tells us the progress of the reaction.

Now, we can look at our two half reactions.

Zn(s) --> Zn2+ + 2 e- Cu2+ + 2 e- --> Cu(s)

During the first half-reaction, our solid zinc metal loses two electrons, and during the second half-reaction, the copper ions in solution gain two electrons.

Loss of Electrons is Oxidation, and so the solid zinc electrode is being oxidized to form zinc two plus ions.

Gain of Electrons is Reduction so copper two plus ions are being reduced to form solid copper. Remember that LEO the lion goes GER!

To get the overall equation, we add the two half-reactions together and get solid zinc plus copper two plus ions yields zinc two plus ions and solid copper.

Overall, two moles of electrons are transferred during our redox reaction. So N equals two.

To get Q, we take the concentration of zinc two plus ions divided by the concentration of copper two plus ions.

Since both ion concentrations are 1.0 molar, Q is equal to 1.0 divided by 1.0 which is one.

When we plug all that in to the Nernst equation, we find that the instantaneous voltage is equal to positive 1.10.

The second term in the Nernst equation turns out to be equal to zero, because the logarithm of Q is the logarithm of one, which is zero.

So the instantaneous voltage is equal to the standard voltage.

In this case it’s positive 1.10 volts at the instant when we close the switch.

The reason why this makes sense is because we’re at standard conditions, the ion concentration in both compartments is 1.0 molar.

Now let’s change things up. Let’s keep the zinc ion concentration at 1.0 molar, but increase the copper ion concentration from 1.0 molar to 10.0 molar.

Now we have nonstandard conditions. Let’s calculate Q at the moment that we close the switch.

At that moment, Q equals the concentration of zinc two plus divided by the concentration of copper two plus. So 1.0 divided by 10.0 or 0.10.

We can plug this new Q into the Nernst equation to give us a new instantaneous voltage.

We start with Ezero, which is still positive 1.10 volts.

From this number we next subtract 0.0592 divided by N, times the log of Q.

N is still two, but now the reaction quotient is 0.10.

The log of 0.10 gives us a negative number, which we multiply by 0.0592 divided by 2.

Because this number is negative, we end up adding this number to 1.10 in order to give an instantaneous voltage of positive 1.13 volts.

Notice what’s happened: when Q was equal to 1.0, the voltage was 1.10, and when Q was decreased to 0.10, the voltage increased to 1.13.

So more generally, when you decrease the reaction quotient, you increase the instantaneous voltage.

Now, let’s change things up again. Let’s keep the copper ion concentration at 1.0 molar, but increase the zinc ion concentration from 1.0 molar to 10.0 molar.

So we have nonstandard conditions again. Let’s calculate Q at the moment that we close the switch.

At that moment, Q equals the concentration of zinc two plus divided by the concentration of copper two plus. So 10.0 divided by 1.0, or 10.0.

We can plug this new Q into the Nernst equation to give us a new instantaneous voltage.

We start with Ezero, which is still positive 1.10 volts.

From this number we next subtract 0.0592 divided by N, times the log of Q.

Key Takeaways

The Nernst equation is a mathematical relationship that explains how a Galvanic cell works and allows us to find the instantaneous voltage of a cell at a specific moment in time.

Its expression is:

E = E0 - (RT/zF)lnQ

Where:

E is the potential difference across the membrane (in volts) E0 is the equilibrium potential for the ion (in volts) R is the universal gas constant T is the temperature (in Kelvin) z is the charge of the ion F is the Faraday constant Q is the reaction quotient